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plans were automatically generated for each patient, one for 
CK with 3 mm PTV margin, and two for VMAT with 3 and 5 
mm PTV margin, respectively. 
 
Results: With automated planning, high quality CK and VMAT 
plans could be generated without user dependency and trial-
and-error approach. PTV coverage was similar for the 3 
approaches, with on average a V100% of 95.2, 95.4%, and 
94.1% for CK, VMAT-3mm and VMAT-5mm. However, for some 
VMAT plans with 5mm margin, coverage > 95% was not 
feasible. Mean values for rectum D1cc were 26.1, 28.5, and 
34.3 Gy, for rectum Dmean 6.3, 7.1, and 10.8 Gy, for bladder 
D1cc 37.7, 37.3, and 39.4 Gy, and for bladder Dmean 8.7, 
7.5, and 9.2 Gy, for CK, VMAT-3mm and VMAT-5mm, 
respectively. Rectum doses were lower with CK compared to 
VMAT-3mm (p = 0.015 and p = 0.08 for rectum D1cc and 
Dmean) and highly decreased compared to VMAT-5mm (p = 
0.007 and 0.008). Bladder sparing worsened slightly with CK 
compared to VMAT-3mm, but this was not statistically 
significant. No relevant differences were found for other 
OARs. With CK, the low-medium dose bath was reduced 
compared to VMAT: V10Gy = 1157.5, 1525.6, 1741.8 cc, 
V20Gy = 286.3, 325.5, 382.0 cc, for CK, VMAT-3mm and 
VMAT-5mm, respectively, with p = 0.007 and p=0.008 for CK 
comparing to VMAT 3 and 5 mm. 
 
Conclusion: The first system for automated generation of 
clinically deliverable Cyberknife plans was built and used for 
unbiased plan comparison with VMAT at a linac. Optimized 
non-coplanar setups showed better rectum sparing compared 
to VMAT plans. This difference was especially large with the 
smaller CK CTV-PTV margin, possible with CyberKnife tumor 
tracking feature. 
 
OC-0268  
Fully automated VMAT plan generation – an international 
multi-institutional validation study 
B. Heijmen
1Erasmus Medical Center Rotterdam Daniel den Hoed Cancer 
Center, Radiation Oncology, Rotterdam, The Netherlands 
1, P. Voet2, D. Fransen1, H. Akhiat2, P. Bonomo3, 
M. Casati3, D. Georg4, G. Goldner4, A. Henry5, J. Lilley5, F. 
Lohr6, L. Marrazzo3, M. Milder1, S. Pallotta3, J. Penninkhof1, 
Y. Seppenwoolde4, G. Simontacchi3, V. Steil6, F. Stieler6, S. 
Wilson5, R. Pellegrini2, S. Breedveld1 
2Elekta AB, Elekta, Stockholm, Sweden 
3Azienda Ospedaliero-Universitaria Careggi, Radiation 
Oncology, Florence, Italy 
4Medical University Vienna /AKH Wien, Radiation Oncology, 
Vienna, Austria 
5St James's Institute of Oncology- St James's Hospital, 
Radiation Oncology, Leeds, United Kingdom 
6University Medical Center Mannheim- Heidelberg University, 
Radiation Oncology, Mannheim, Germany 
 
Purpose or Objective: Recently, iCycle/Monaco, a system for 
fully automated, multi-criterial plan generation, consisting of 
the in-house iCycle optimizer and Monaco (Elekta AB, 
Stockholm, Sweden) has been developed. Sofar, the system 
was only validated in a single institution. In this study, 
iCycle/Monaco was validated in 4 independent centers for 
prostate cancer VMAT. Hypothesis of the study was that 
automatically generated plans had similar or superior quality 
compared to plans generated by manual planning in clinical 
routine, using the Monaco TPS only. 
 
Material and Methods: For each of the 4 centers, plans of 10 
recently treated patients were used to configure 
iCycle/Monaco. For 20 independent patients, manually 
generated VMAT plans (MANplan) were then compared with 
automatically generated VMAT plans (AUTOplan). Plans were 
compared using dose-volume parameters and by ‘blind’ 
scoring by treating physicians. The scoring of the plans by 
physicians was performed in 2 sessions: A) the in total 40 
anonymized plans (20 AUTO, 20 MAN) were evaluated in 
random order to assess clinical acceptability, B) for each of 
the 20 patients, the AUTOplan and MANplan were compared 
to select the most favorable plan. In these comparisons, 
plans could be scored as i) of higher quality with a clinically 
relevant difference, ii) of higher quality but with a low 
clinical impact, or iii) of similar quality. In one participating 
center, plan scoring was performed independently by 2 
physicians. 
Results: A total of 200 separate plan evaluations and 100 
plan comparisons were made in this study. In the separate 
plan evaluations, 100% of MANplans and 98% of AUTOplans 
were clinically acceptable. The 2 AUTOplans that were not 
clinically acceptable had too high bowel dose, which was due 
to the absence of patients with small bowel delineation 
among the patients used for configuration of iCycle/Monaco 
in 2 centers. For 38/100 plan comparisons, the AUTOplan was 
considered superior to the MANplan, with high clinical 
relevance. Only in 9 comparisons, the MANplan was superior 
with high relevance for the patient. In all other comparisons, 
differences were absent or of minor clinical relevance 
(Figure). With similar PTV coverage, dose delivery to OARs 
was on average lower for the AUTOplans: -14.8%, -24.6%, and 
-14.6% for rectum V75, V60, and Dmean (p=0.001, p<0.001, 
p<0.001), and -5.1% for bladder Dmean (p=0.009). 
 
Frequency histogram showing the scores for 100 comparisons 
of an automatically (AUTO) and a manually (MAN) generated 
plan.  
 
Conclusion: In an international, multi-institutional setting, 
automatic planning for prostate cancer has proven to be 
overall superior to manual planning. Automated planning 
avoids planning workload and contributes to standardized 
radiotherapy treatment with high plan quality. 
 
Proffered Papers: RTT 3: Ensuring quality in head and neck 
treatment  
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Purpose or Objective: Simultaneously integrated boost (SIB) 
used in many sites, replanning is not made. In SIB of 
intensity-modulated radiotherapy (IMRT), doses per fraction 
are often unconventional, because of equal fractions treating 
multiple targets. We assessed sequential SIB (SEQ-SIB) to 
resolve the problem. The purpose of this study is to compare 
dosimetric parameters of SEQ-SIB with those of SIB using 
deformable imaging registration (DIR) for head and neck 
cancer patients. 
 
Material and Methods: Subjects were 10 cases HNC treated 
with IMRT at our institute in 2014. In all cases, high-risk 
planning target volume (PTVboost) was based on the primary 
tumor and clinical lymph node metastases, while 
PTVelective(PTVel) included bilateral cervical nodal areas. 
The D95 was defined as the prescribed dose. For SIB, doses 
were 66 and 54 Gy in 30 fractions to PTVboost and PTVel, 
respectively. For SEQ-SIB, they were 55 Gy to PTVboost and 
50 Gy to PTVel in 25 fractions using SIB, followed by 11 Gy in 
5 fractions to PTVboost.We chose to maintain the size of the 
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original GTV when contouring the GTV on the anatomy of the 
second CT scan.SIB created two plans. One is 1st CT / 1st 
Plan and the other is SIB sum (25 fractions (deformed CT) and 
5 fractions ( 2nd CT )) . A deformed CT (dCT) with structures 
was created by deforming the 1st CT to the 2nd CT. We 
summed up dose used in 1st Plan and 2nd Plan using a 
commercially software ( MIM Maestro 6.3 ). The two types of 
plans were compared with respect to DVHs for other 
dosimetric parameters of the PTVboost, PTVel, brainstem, 
spinal cord and parotid gland. 
 
Results: The mean dose for the brainstem, the spinal cord 
and the parotid was lower for SEQ. The D95of PTVboost and 
PTVel were significantly lower for SIB sum than for SIB ( 
p<0.003, p<0.02 ).The D95 of PTVboost and PTVel were 
significantly lower for SIB sum than for SEQ-SIB ( p<0.03, 
p<0.03 ). The difference between the CI of PTVboost of SIB 
sum and that of SEQ-SIB was not significant ( p=0.03 ). The CI 
of PTVel was significantly lower for SIB sum than for SEQ-SIB ( 
p<0.001). 
 
 
 
Conclusion: SEQ-SIB is an approach for resolving the fraction 
size problem posed by SIB. The dosimetric parameters for 
OARs showed some variation between SIB and SEQ-SIB, 
especially for the parotid glands. SEQ-SIB is good in the point 
of coverage of PTV, because of replanning. The mean dose 
for ipsilateral and contralateral parotid was lower for SEQ-
SIB, because of the lower elective dose. The availability of 
SEQ-SIB using replanning was suggested. 
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Purpose or Objective: Dose to parotid glands in IMRT 
depended on the setting of constraints during inverse 
planning and could be varied by planners’ experience. This 
study aimed to tackle the problem of IMRT plan variability by 
the development of a multiple regression model to associate 
parotid dose and anatomical factors. By measuring a few 
anatomical factors before performing inverse planning, 
reference parotid dose would be suggested by the model to 
guide planners to undergo the inverse planning optimization 
process. 
 
Material and Methods: 25 NPC subjects who previously 
received radical IMRT (70Gy/60Gy/54Gy in 33-35 fractions) 
were randomly selected. Optimized IMRT plans produced by a 
single planner were used for data collection. Multiple 
regression was performed using parotid gland Dmean, and 
D50% as the dependent variable, and various anatomical 
factors as the independent variable. The anatomical factors 
included (1) gland size, (2) %volume with 1cm gap from 
PTV60, (3) volume with 1cm gap from PTV60, (4) %volume 
overlap with PTV60, (5) volume overlap with PTV60, (6) 
%volume overlap with PTV70, (7) volume overlap with PTV70 
(8) max. distance from PTV60 and (9) max. distance from 
PTV70. Gland size was measured using the “measure volume” 
function. Volume with 1cm gap was measured by using “crop 
structure” function and cropping the parotid with 1cm gap 
from the PTV60. Volume overlap with PTV was measured by 
using the “Boolean operator” which created the overlapped 
volume. Max. distance was measured by the magnitude of 
expanding the PTV using the “margin for structure” function 
until the PTV covered the whole parotid gland. Multiple 
regression was performed using the stepwise method which 
eliminated independently variables with least effect. 
 
Results: Anatomical factors statistical significantly predicted 
parotid gland Dmean and D50%. For Dmean, gland size, 
%volume overlap with PTV60 and %volume with 1cm gap from 
PTV60 were included in the model. (F(3, 46) = 44.244, 
p<0.0005, R2 = 0.743). For D50%, volume overlap with PTV60, 
%volume with 1cm gap from PTV60 and gland size were 
included in the model. (F(3, 46) = 37.709, p<0.0005, R2 = 
0.711).  
 
Conclusion: These models explained over 70% of the 
dependent variables. Cross validation will be provided to 
support the accuracy of the model. The predicted parotid 
dose could be used for a guide to set dose constraints during 
inverse planning and as the benchmark dose during plan 
evaluation. Eventually the suggested model could improve 
the parotid sparing in the IMRT of NPC cases. 
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Purpose or Objective: Our aim was to investigate the 
feasibility of a three-dimensional (3D)-printed head-and-neck 
(HN) immobilization device by comparing its positional 
accuracy with that of the conventional thermoplastic mask. 
 
Material and Methods: We prepared a 3D-printed 
immobilization device (3DID) consisting of a mask and 
headrest developed from the computed tomography (CT) 
data obtained by imaging an HN phantom. The CT data was 
reconstructed to generate the Digital Imaging and 
Communication in Medicine (DICOM) dataset. Then, the HN-
phantom surface was determined by the Otsu segmentation 
method. After converting the DICOM dataset of the phantom 
surface to a Surface Tessellation Language (STL) file format, 
3D modeling was performed. Next, the STL file was 3D 
printed using acrylonitrile–butadiene–styrene resin. For 
comparison of positional accuracy, the conventional 
immobilization device (CID) composed of a thermoplastic 
mask and headrest was prepared using the same HN 
phantom. Subsequently, the simulation CT images were 
acquired after fixing the HN phantom with 3DID. After 
positioning the HN phantom by matching surface marks, 
radiographs were acquired using the ExacTrac X-ray image 
system. Then, we quantified the positional deviations, 
including three translations and three rotations, between the 
coordinate origin in the localization images prepared from kV 
X-rays and the expected position on the digitally 
reconstructed radiograph from the simulation CT images. This 
process was repeated fifteen times to collect data on 
positional deviations. Afterwards, the same procedure was 
performed in the same HN phantom fixed with CID for 
comparison. 
 
Results: The translational displacement (mean [standard 
deviation, SD]) in the vertical, lengthwise, and lateral 
directions was −0.28 [0.09], −0.02 [0.08], and 0.31 [0.27] 
[maximum, 0.81 mm (lateral direction)] for 3DID and 0.29 
[0.06], 0.03 [0.14], and 0.84 [0.27] [maximum, 1.23 mm 
(lateral direction)] for CID, respectively. The rotational shift 
in the yaw, roll, and pitch directions was 0.62 [0.13], 0.08 
[0.74], and −0.31 [0.08] [maximum, −0.41° (pitch direction)] 
for 3DID and −0.15 [0.17], 0.17 [0.67], and −0.09 [0.06] 
[maximum, −1.23° (roll direction)] for CID, respectively. The 
